A microaggregation framework for reproducible research with observational data: addressing biases while protecting personal identities
A microaggregation framework for reproducible research with observational data: addressing biases while protecting personal identities
批准号:
9306948
负责人:
Christophe G. Lambert
金额:
$16.29万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-01 至 2019-06-30
关键词:
ALPPAddressAdverse drug eventArchitectureClinical TrialsCommunitiesConflict (Psychology)DataData ScienceData SourcesDatabasesDepositionDisclosureDiseaseEffectivenessElectronic Health RecordEventEvidence Based MedicineExperimental DesignsFamilyFosteringFoundationsFuture GenerationsGene ExpressionGene ProteinsGoalsHealthHealthcareIncidenceIndividualInformaticsKnowledgeLearningLiteratureManuscriptsMapsMeasuresMedicalMedicineMethodologyMethodsMissionModelingObservational StudyOnset of illnessOutcomePatient-Focused OutcomesPatientsPharmacotherapyPrivacyRandomizedRandomized Controlled TrialsRecordsReproducibilityResearchRestRiskSafetyScienceSecureSignal TransductionSurvival AnalysisSystemTaxonomyTechnologyTimeUpdatealternative treatmentbasecase controlclinical practicecomparative effectivenessdata accessdata formatdata sharingdatabase querydesigneffectiveness researchhealth datahealth recordimprovedindividual patientinnovationinterestknowledge basemembernovelpatient privacypoint of careprecision medicinepreventprogramsrepositorysuccesstreatment choice
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The primary objective of the current proposal is to foster efforts towards transparent and
reproducible knowledge repositories for evidence-based medicine. The wealth of healthcare
data already available in electronic health records could be better utilized to help guide
treatment choices and compliment findings from randomized controlled trials. This proposal
addresses two major obstacles. The first is the challenge of deriving high-quality evidence from
observational data in the presence of biases and confounders, particularly with temporal data.
The second is that patient privacy and other concerns prevent disclosure of source data, which
hinders reproducible research -- currently there is a vast body of medical literature whose
findings guide clinical practice, yet cannot be independently scrutinized. We will address these
challenges through an innovative methodology, local control, which both corrects biases and
enables disclosure of question-specific microaggregated data to reproduce research findings
without disclosure of individual information. The key idea behind local control is to form many
homogeneous patient clusters within which one can compare alternate treatments, statistically
correcting for measured biases and confounders, analogous to a randomized block design. Our
methodology provides a unified framework for enabling open, high quality, comparative
effectiveness research by combining novel feature selection approaches, based on fractional
factorial experimental design, with advances in survival analysis, including competing risks. We
will create a public R package containing a family of methods for nonparametric bias correction
and statistical disclosure control in cross-sectional, case-control, and survival analysis settings.
Success of this research will also enable a novel model, we term “parcelled data sharing” to
facilitate open selective release of proprietary data sources for specific questions --
simultaneously protecting patient privacy, proprietary interests, and the public good. Our
research will contribute to the goal of evidence-based medicine being supported by national and
global knowledge bases on thousands of comparative effectiveness questions from 100’s of
millions of patients’ health records. This application supports the NLM mission by assisting in
the advancement of medical and related sciences through the dissemination and exchange of
important information to the progress of medicine and health. The specific aims are to (1)
Develop and evaluate a survival-based local control methodology for bias-corrected treatment
comparisons in time-to-event observational data; and (2) Develop and evaluate local control-
based microaggregation for reproducible research.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.18637/jss.v096.i04
发表时间:
2020
期刊:
Journal of statistical software
影响因子:
5.8
作者:
[Lauve NR, Nelson SJ, Young SS, Obenchain RL, Lambert CG]
通讯作者:
Lambert CG
Deriving high-quality evidence from national healthcare databases to improve suicidality detection and treatment outcomes in PTSD
-
批准号:10587966
-
项目类别:
-
资助金额:$74.43万
-
财政年份:2022
-
负责人:Christophe G. Lambert
-
依托单位:
Deriving high-quality evidence from national healthcare databases to improve suicidality detection and treatment outcomes in PTSD and TBI
-
批准号:10088135
-
项目类别:
-
资助金额:$77.62万
-
财政年份:2020
-
负责人:Christophe G. Lambert
-
依托单位:
Illuminating the Druggable Genome Data Coordinating Center - Engagement Plan with the CFDE
-
批准号:10217890
-
项目类别:
-
资助金额:$44.7万
-
财政年份:2020
-
负责人:Christophe G. Lambert
-
依托单位:
Illuminating the Druggable Genome Data Coordinating Center - Engagement Plan with the CFDE
-
批准号:10683510
-
项目类别:
-
资助金额:$40.62万
-
财政年份:2020
-
负责人:Christophe G. Lambert
-
依托单位:
Illuminating the Druggable Genome Data Coordinating Center - Engagement Plan with the CFDE
-
批准号:10907966
-
项目类别:
-
资助金额:$56.21万
-
财政年份:2020
-
负责人:Christophe G. Lambert
-
依托单位:
Illuminating the Druggable Genome Data Coordinating Center - Engagement Plan with the CFDE
-
批准号:10468527
-
项目类别:
-
资助金额:$74.53万
-
财政年份:2020
-
负责人:Christophe G. Lambert
-
依托单位:
Software Relating Genes to Disease and Clinical Outcomes
-
批准号:6582179
-
项目类别:
-
资助金额:$53.9万
-
财政年份:2001
-
负责人:Christophe G. Lambert
-
依托单位:
Software Relating Genes to Disease and Clinical Outcomes
-
批准号:6341382
-
项目类别:
-
资助金额:$9.97万
-
财政年份:2001
-
负责人:Christophe G. Lambert
-
依托单位:
Software Relating Genes to Disease and Clinical Outcomes
-
批准号:7013551
-
项目类别:
-
资助金额:$6.9万
-
财政年份:2001
-
负责人:Christophe G. Lambert
-
依托单位:
Software Relating Genes to Disease and Clinical Outcomes
-
批准号:6693828
-
项目类别:
-
资助金额:$41.65万
-
财政年份:2001
-
负责人:Christophe G. Lambert
-
依托单位:
海外基金